Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein ...
Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...
Henry Schein has received a strategic investment of $250 million from KRR, giving the global investment firm a 12% stake in the company, with the option to purchase additional shares ...